Literature DB >> 16306486

Comparison of prostate cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000).

Tomomi Marugame1, Shoichi Mizuno.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16306486     DOI： 10.1093/jjco/hyi185

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  12 in total

1.  Impact of the duration of hormonal therapy following radiotherapy for localized prostate cancer.

Authors:  Mitsuru Okubo; Hidetugu Nakayama; Tomohiro Itonaga; Y U Tajima; Sachika Shiraishi; Ryuji Mikami; Akira Sakurada; Shinji Sugahara; Kiyoshi Koizumi; Koichi Tokuuye
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

2.  Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

Authors:  Matthew J Roberts; Horst J Schirra; Martin F Lavin; Robert A Gardiner
Journal:  Korean J Urol       Date:  2011-02-19

3.  Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.

Authors:  Edward W Howard; Steve C L Leung; H F Yuen; Chee Wai Chua; Davy T Lee; K W Chan; Xianghong Wang; Yong Chuan Wong
Journal:  Clin Exp Metastasis       Date:  2008-03-14       Impact factor: 5.150

4.  Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis.

Authors:  Toshifumi Kurahashi; Hideaki Miyake; Masashi Shinozaki; Nobutoshi Oka; Atsushi Takenaka; Isao Hara; Yosuke Matsumura; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

5.  Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers.

Authors:  Natalia Yu Anisimova; Andrey V Sosnov; Nadezhda E Ustyuzhanina; Gianfranco Baronzio; Mikhail V Kiselevsky
Journal:  ISRN Oncol       Date:  2011-08-17

6.  The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.

Authors:  Kenji Nakayama; Takahiro Inoue; Sadanori Sekiya; Naoki Terada; Yu Miyazaki; Takayuki Goto; Shigeki Kajihara; Shin-Ichiro Kawabata; Shinichi Iwamoto; Kuniko Ikawa; Junko Oosaga; Hiroaki Tsuji; Koichi Tanaka; Osamu Ogawa
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

7.  Focal treatment of prostate cancer with vascular-targeted photodynamic therapy.

Authors:  Scott E Eggener; Jonathan A Coleman
Journal:  ScientificWorldJournal       Date:  2008-10-03

Review 8.  Omega-3 PUFAs Lower the Propensity for Arachidonic Acid Cascade Overreactions.

Authors:  Bill Lands
Journal:  Biomed Res Int       Date:  2015-08-02       Impact factor: 3.411

9.  Treatment pathways of Japanese prostate cancer patients - A retrospective transition analysis with administrative data.

Authors:  Stephane Cheung; Yukinobu Hamuro; Jörg Mahlich; Masahiko Nakayama; Akiko Tsubota
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

10.  Grain and dietary fiber intake and bladder cancer risk: a pooled analysis of prospective cohort studies.

Authors:  Evan Y W Yu; Anke Wesselius; Siamak Mehrkanoon; Maree Brinkman; Piet van den Brandt; Emily White; Elisabete Weiderpass; Florence Le Calvez-Kelm; Marc Gunter; Inge Huybrechts; Fredrik Liedberg; Guri Skeie; Anne Tjonneland; Elio Riboli; Graham G Giles; Roger L Milne; Maurice P Zeegers
Journal:  Am J Clin Nutr       Date:  2020-11-11       Impact factor: 7.045
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.